Bottom line
How much do PHLAX and JEHSX overlap?
52% of their top holdings overlap by weight. 9 securities appear in both funds' top 25, making up 48.2% of PHLAX's assets and 35.9% of JEHSX's. They share a meaningful core but differ in the rest of the portfolio.
JEHSX holds far more positions (173 vs 55), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings PHLAX and JEHSX have in common
| Holding | % of PHLAX | % of JEHSX | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 17.35% | 14.30% | 14.30% |
| Merck & Company Inc MRK | 6.06% | 4.21% | 4.21% |
| Unitedhealth Group Inc UNH | 5.87% | 5.95% | 5.87% |
| Thermo Fisher Scientific Inc TMO | 4.56% | 2.67% | 2.67% |
| Vertex Pharmaceuticals Inc VRTX | 3.37% | 2.38% | 2.38% |
| Danaher Corp DHR | 3.28% | 1.51% | 1.51% |
| Intuitive Surgical Inc ISRG | 3.07% | 1.98% | 1.98% |
| Cvs Health Corp CVS | 2.52% | 0.98% | 0.98% |
| Stryker Corp SYK | 2.16% | 1.87% | 1.87% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in PHLAX
- Argenx Se — 3.55%
- Lonza Group Ag — 3.02%
- (PIPA070) PGIM Core Government Money Market Fund — 2.50%
- Insmed Inc — 2.28%
- Roivant Sciences Ltd — 2.21%
- Sionna Therapeutics Inc — 2.01%
- Beone Medicines Ltd — 1.82%
- Vaxcyte Inc — 1.77%
- Align Technology Inc — 1.75%
- Agilent Technologies Inc — 1.73%
- Palvella Therapeutics Inc — 1.56%
- Apogee Therapeutics Inc — 1.42%
- Cabaletta Bio Inc — 1.35%
- Prudential Investment Portfolios 9 — 1.31%
- Newamsterdam Pharma Company Nv — 1.30%
Only in JEHSX
- Johnson and Johnson — 6.33%
- AbbVie Inc. — 5.28%
- Gilead Sciences Inc. — 2.95%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
- Amgen Inc. — 1.90%
- Elevance Health Inc. — 1.63%
- Natera Inc. — 1.49%
- Guardant Health Inc. — 1.28%
- Cardinal Health Inc. — 1.09%
- Royalty Pharma plc — 1.02%
- Tenet Healthcare Corporation — 0.99%
- Kymera Therapeutics Inc. — 0.93%
- Protagonist Therapeutics Inc. — 0.90%
- BrightSpring Health Services Inc. — 0.88%
Asset mix
| Asset type | PHLAX | JEHSX |
|---|---|---|
| Stocks | 97.8% | 99.0% |
| Cash & short-term funds | 3.8% | 0.9% |
| Bonds | — | 0.1% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Country mix
| Country | PHLAX | JEHSX |
|---|---|---|
| US | 84.7% | 95.0% |
| NL | 5.4% | 1.0% |
| CH | 4.8% | 0.3% |
| BM | 2.2% | — |
| GB | 1.1% | 0.8% |
| CA | 1.0% | — |
| IL | 1.0% | 0.2% |
| DE | 0.9% | 0.2% |
Source: SEC Form N-PORT (periods May 29, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do PHLAX and JEHSX overlap?
What stocks do PHLAX and JEHSX have in common?
Should I own both PHLAX and JEHSX?
Which holds more stocks, PHLAX or JEHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.